About Ascendia Pharmaceutical Solutions
Ascendia Pharmaceutical Solutions is a Healthcare company based in North Brunswick (United States) founded in 2012 by Jim Jingjun Huang. Formulation, analytical, and manufacturing services are provided for pharmaceutical companies. Ascendia Pharmaceutical Solutions has raised $6.58 million across 2 funding rounds. Its chief executive, as recorded, is Jim Jingjun Huang. Its website ascendiacdmo.com draws about 41 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides.
Company details
Founded in 2012, Ascendia Pharmaceutical Solutions operates as a contract development and manufacturing organization in North Brunswick, United States. Services encompass formulation development, analytical testing, and GMP-compliant manufacturing for small molecules, biologics, and gene delivery systems. Nanotechnologies are utilized to resolve solubility issues in drug products. Additional offerings include sterile parenteral and oral solid dosage forms, ICH stability studies, and pre-formulation support for clinical trial materials.
- Headquarters North Brunswick, United States
- Founders Jim Jingjun Huang
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ascendiacdmo.com
- Social LinkedIn
- Legal Name Ascendia Pharmaceutical Solutions
- Total Equity Funding$6.58M (USD)
in 2 rounds
- Latest Funding Round$4.08M (USD), Series A
Jun 2026
Funding Insights of Ascendia Pharmaceutical Solutions
Ascendia Pharmaceutical Solutions has successfully raised a total of $6.58M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.08 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.58M
- Total Rounds 2
- Last Round Series A — $4.08M
- First Round $2.5M
(May 2025)
All 2 funding rounds of Ascendia Pharmaceutical Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2026 | $4.08M | Series A | – | – | – |
| May 2025 | $2.5M | Seed | – | – | – |
People of Ascendia Pharmaceutical Solutions
1 people are tracked at Ascendia Pharmaceutical Solutions (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jim Jingjun Huang | Founder & CEO | Leadership |
Complete people profiles for Ascendia Pharmaceutical Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ascendia Pharmaceutical Solutions
3 dated milestones of Ascendia Pharmaceutical Solutions across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Ascendia Pharmaceutical Solutions is founded.
- Funding First funding round of $2.5M.
- Funding Latest funding round, Series A, of $4.1M.
Web traffic of Ascendia Pharmaceutical Solutions
The website of Ascendia Pharmaceutical Solutions (ascendiacdmo.com) receives about 41.2K visits a month.
- Monthly visits41.2K
▼ 29.7% vs previous month
Websites whose visitors overlap most with Ascendia Pharmaceutical Solutions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nexomics.com | 100% | 1.3K | #11,468,977 | View details | |
| raritanpharm.com | 99% | 1.8K | #11,430,509 | View details | |
| prolongpharma.com | 98% | 3.8K | #13,715,654 | View details | |
| akrospharma.com | 98% | 1.5K | #10,598,752 | View details | |
madescientific.com | madescientific.com | 97% | #6,026,167 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Ascendia Pharmaceutical Solutions
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Ascendia Pharmaceutical Solutions (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ascendia Pharmaceutical Solutions
Ascendia Pharmaceutical Solutions was founded in 2012 and raised its 1st funding round 13 years after it was founded.
Ascendia Pharmaceutical Solutions is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
Jim Jingjun Huang is the CEO of Ascendia Pharmaceutical Solutions, as recorded in our data. They have also founded this company.
Ascendia Pharmaceutical Solutions is a funded company, having raised a total of $6.58M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.5M, raised on May 2025.
Founded in 2012, Ascendia Pharmaceutical Solutions operates as a contract development and manufacturing organization in North Brunswick, United States. Services encompass formulation development, analytical testing, and GMP-compliant manufacturing for small molecules, biologics, and gene delivery systems. Nanotechnologies are utilized to resolve solubility issues in drug products. Additional offerings include sterile parenteral and oral solid dosage forms, ICH stability studies, and pre-formulation support for clinical trial materials.
Ascendia Pharmaceutical Solutions operates through Ascendia Pharmaceutical Solutions.